Volkan Manga M.D.

Volkan Manga MD currently serves as Chief Medical Officer at Uniquity Bio, a position held since December 2024. Previously, Volkan Manga held several leadership roles at AstraZeneca, including Global Franchise Head of Respiratory & Immunology R&D from April 2023 to December 2024, and was with Novartis from January 2013 to April 2023, where titles included VP US New Products Medical Unit Head and Executive Director for Dermatology & Rheumatology Clinical Development. Earlier experience encompasses positions at Novo Nordisk and AstraZeneca, focusing on areas such as respiratory, oncology, diabetes, and hemostasis. Volkan Manga's educational background includes ongoing studies towards an MSc in Immunology and Immunogenetics at The University of Manchester and a Business Awareness Certification Program at Babson College, along with medical degrees from Cukurova University and the State Hospital of Agri.